DYRK2 has been reported to trigger antitumor and pro-apoptotic signals, while in parallel other studies identified DYRK2 as a highly overexpressed kinase in various cancer types and DYRK2 inhibitors were shown to exhibit antiproliferative properties (Tandon et al., 2021). The gene discussed is DYRK2; the disease is cancer.